Together Pharma Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	59	54	34	19	68	136
Market Cap Growth	-2.03%	58.74%	82.58%	-72.51%	-50.07%	-23.85%
Enterprise Value	102	112	92	61	138	177
Last Close Price	3.37	3.92	3.88	2.48	10.62	24.31
PE Ratio	-	-	-	-	-	19.02
PS Ratio	0.54	0.56	0.38	0.60	5.65	12.12
PB Ratio	1.18	1.42	-13.36	6.18	2.64	9.24
P/TBV Ratio	2.80	6.29	-	-	-	-
P/FCF Ratio	6.35	39.38	2.44	-	-	-
P/OCF Ratio	6.04	18.99	2.30	-	-	-
EV/Sales Ratio	0.93	1.16	1.01	1.97	11.50	15.80
EV/EBITDA Ratio	13.86	12.52	3.33	-	-	8.63
EV/EBIT Ratio	270.96	34.17	4.16	-	-	10.66
EV/FCF Ratio	11.03	81.38	6.58	-	-	-
Debt / Equity Ratio	1.01	1.66	-21.48	19.88	3.32	3.89
Debt / EBITDA Ratio	6.80	6.29	1.92	-	-	2.74
Debt / FCF Ratio	5.41	46.26	3.92	-	-	-
Net Debt / Equity Ratio	0.81	1.44	-20.07	18.13	3.12	3.50
Net Debt / EBITDA Ratio	6.55	6.17	1.85	-3.81	-13.08	2.51
Net Debt / FCF Ratio	4.38	40.12	3.67	-3.89	-3.98	-2.19
Asset Turnover	0.71	0.67	0.68	0.22	0.09	0.12
Inventory Turnover	1.54	1.41	1.13	0.82	0.34	-
Quick Ratio	0.43	0.36	0.27	0.29	0.09	0.37
Current Ratio	1.11	1.07	1.17	1.25	1.32	2.12
Return on Equity (ROE)	-14.88%	-9.09%	-1076.01%	-246.99%	-74.80%	1175.31%
Return on Assets (ROA)	0.15%	1.43%	10.29%	-8.57%	-5.04%	10.77%
Return on Invested Capital (ROIC)	0.42%	4.61%	-68.34%	-24.14%	-13.31%	45.63%
Return on Capital Employed (ROCE)	0.50%	4.80%	28.90%	-24.00%	-12.40%	16.00%
Earnings Yield	-11.21%	-2.17%	-12.66%	-179.57%	-20.28%	5.26%
FCF Yield	15.75%	2.54%	40.97%	-75.34%	-29.70%	-17.24%
Buyback Yield / Dilution	-41.07%	-41.39%	-7.81%	-18.96%	-18.76%	-14.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.